Joseph Bryer MD in Wilmington, Delaware

Home Delaware Wilmington

Joseph Bryer MD has Psychiatry as his primary medical specialty. Their primary office is: 1521 Concord Pike in Wilmington, Delaware. They attended Medical College Of Pennsylvania and graduated in 1985 (around 39 years of experience). They are listed as doing telehealth appointments.

Joseph B Bryer MD Office Phone and Directions

Joseph Bryer MD
1521 Concord Pike
Wilmington, Delaware 19803
302-426-9440

Patient Ratings
Please rate your experience with Joseph Bryer MD below to help others make a more informed decision. Thanks!

Current Rating: Loading...

Phone: 302-426-9440

Enter a starting address:

Healthcare Info for Joseph Bryer MD

Medical School: Medical College Of Pennsylvania
Graduation Year: 1985
The Primary Medical Specialty for Joseph Bryer MD is listed as: Psychiatry
Credentials: MD
Additional Credentials:
Approximate Years of Experience: 39
PAC (PECOS ID)#: 8921107723
NPI #: 1619904331
NPI Created On: 06/27/2006
NPI Last Updated Listed as: 07/08/2007
Primary Taxonomy Code: 2084P0800X
License Number:
C10003547
Listed Gender: Male

Insurance, Services, Charges

Forms of insurance accepted by include, but are not limited to:

Highmark BCBSD Inc.
Medicare

They are listed as accepting new patients.

Languages spoken by staff include: English.

Services and Procedures include:

Psychotherapy, 30 minutes
Shock treatment and monitoring
Established patient office or other outpatient visit, typically 15 minutes
Established patient office or other outpatient, visit typically 25 minutes

They took part in the Medicare Physician Quality Reporting System (PQRS).

Open Payments Data. This can include items to test (Durable Medical Equipment (DME)), Biological, Drug Samples, etc. This data must be reported to CMS.

Payments Total: $28

Number of Payments:: 1

Form of Payment: In-kind items and services

Record ID:: 794175683

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: NEUROSCIENCE

Name of Drug #1: VRAYLAR

Open Associated Drug #1: 61874-115-31